Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Bi-Specific MAbS Market?

The market size of primary cell culture has experienced rapid expansion lately. The market is projected to rise from $6.79 billion in 2024 to $7.76 billion in 2025, registering a Compound Annual Growth Rate (CAGR) of 14.2%. The phenomenal growth during the historic period was primarily driven by a rising demand for monoclonal antibodies, escalating need for novel therapeutics, an upsurge in interest towards personalized medicine as well as an increasing demand in the field of cell therapy research.

In the coming years, a swift expansion is anticipated for the primary cell culture market, with an estimated market size of “$13.03 billion in 2029“, growing at a compound annual growth rate (CAGR) of 13.8%. The rise in cancer prevalence, growth in the pharmaceutical and biotech sectors, increased demand for customized medicine, and 3D cell culture model applications contribute to the market’s growth during the forecast period. Technological progress, innovation in products, partnerships, and research and development are noted as major trends for the forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15903&type=smp

Which Factor Is Shaping The Future Of The Bi-Specific MAbS Market?

The escalating incidence of cancer and other chronic illnesses is expected to fuel the expansion of the bispecific monoclonal antibodies market in the forecasted timeline. Bispecific monoclonal antibodies, designed to combat various cancers, infectious diseases, central nervous system disorders, and autoimmune disorders, are seen as more potent than monoclonal antibodies (moAbs) since they target multiple tumor antigens on the cells to halt cancer progression. For instance, the American Cancer Society (ACS), a volunteer health organization based in the US, predicts 609,820 cancer-related fatalities in the US in 2023, as stated in their 2023 Cancer Facts & Figures report. Consequently, an increasing prevalence of chronic illnesses, including cancer, is likely to drive demand for bi-specific MAbs as an effective treatment option.

The primary cell culture market covered in this report is segmented –

1) By Product: Primary Cell, Reagents, Supplements, Media

2) By Cell Type: Animal Cells, Human Cells

3) By Separation And culture Techniques: Explant Method, Enzymatic Disaggregation, Mechanical Separation, Other Separation

4) By Application: Tissue Culture and Tissue Engineering, Vaccine Production, Gene Therapy And Regenerative Medicine, Drug Screening And Toxicity Testing, Cancer Research, Virology, Strem Cell Therapy, Other Applications

5) By End User: Pharmaceutical And Biotechnology Company And Contract Research Organizations, Academic And Research Institutes, Other End Users

Subsegments:

1) By Primary Cell: Human Primary Cells, Animal Primary Cells

2) By Reagents: Enzymes, Buffers And Salts, Antibodies

3) By Supplements: Growth Factors, Serum Supplements, Hormones

4) By Media: Basal Media, Serum-Free Media, Specialty Media

Which Trends Are Redefining The Future Landscape Of The Bi-Specific MAbS Industry?

Significant players in the primary cell culture market, such as Extracellular, are working to construct cell banks that focus on primary cells designed for cultivated meat study, primarily to further the evolution of sustainable and ethically-produced meat technologies. The goal behind the Cell Bank project is not only to aid startup companies and researchers by supplying premium animal primary cells specifically tailored for cultivated meat research and development, but also to do so at a cost that is up to 90% less expensive than rival cell line suppliers, and devoid of any licensing boundaries. For example, in June 2023, Extracellular, a British CDMO (contract development and manufacturing organization), introduced affordable, license-free cell banks to aid the farmed meat market. The cell banks initially offer cells derived from various sources, such as the fat, muscle, and bone marrow of cows, pigs, and lambs. The essence of this initiative remains the collaborative nature, towards enhancing the growth of the cultivated meat industry in the UK, by making cell lines more accessible, and offering researchers and companies a way to pioneer new technologies without being hindered by licensing or commercial contracts.

Which Companies Hold The Largest Market Share In The Bi-Specific MAbS Sector?

Major companies operating in the primary cell culture market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sàrl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies

https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report

How Does Regional Performance Compare Across The Bi-Specific MAbS Industry?

North America was the largest region in the primary cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15903&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model